STOK
Stoke Therapeutics Inc
Halal Rating :
Last Price
$9.36
Last updated:
Market Cap
-
7D Change
4.93%
1 Year Change
88.71%
Company Overview
Industries
Exchange
Next Earnings Date
Stoke Therapeutics Inc is a biotechnology company focused on developing therapies for severe genetic diseases. The company's primary focus is on developing treatments for genetic epilepsies and other severe genetic diseases using their proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) technology platform. They are particularly focused on developing treatments for Dravet syndrome, a severe form of genetic epilepsy.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.89m | $34.9m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $4.83m | $34.17m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $4.22m | $32.59m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Stoke Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.